Veeva Systems earnings calendar in focus, shares tracked on NYSE
25.06.2026 - 18:18:16 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 18:17.
Veeva Systems Inc (US9224171002) sits on many earnings calendars as investors look ahead to the company's next quarterly update after the May report on the New York Stock Exchange. The life sciences software specialist continues to attract analyst coverage, with several brokers maintaining positive stances according to recent research summaries.
What the latest earnings showed
Veeva Systems reported first-quarter fiscal 2026 results for the period ended 30 April 2025, with revenue of about 690 million US dollars and adjusted earnings per share above 1 US dollar, as noted in the company's latest quarterly materials. The official investor relations site provides the detailed Q1 fiscal 2026 presentation with segment breakdowns and guidance commentary.
Management reiterated its strategy of focusing on cloud-based solutions for the global life sciences industry, including clinical, regulatory and commercial applications that support pharmaceutical and biotech clients. The reporting period confirmed continued customer adoption across major markets such as the United States and Europe, where large peers like Salesforce also compete in parts of the customer relationship and data management stack.
Analyst views and consensus picture
Analyst consensus compiled by financial data services shows a majority of brokers rating Veeva Systems as Buy or Overweight, with a smaller group on Hold, reflecting expectations of steady double-digit revenue growth over the medium term. Recent notes from major houses such as Morgan Stanley and Goldman Sachs have highlighted the company's strong position in life sciences cloud software and its high recurring revenue share, even as they point to valuation sensitivity compared with broader software peers. MarketScreener's consensus page for Veeva Systems aggregates target prices and recommendations from a range of banks and research houses.
Several analysts emphasize Veeva Systems' long-term contracts and customer retention rates as a stabilizing factor for cash flows, while also flagging potential headwinds from slower decision cycles at large pharma clients and ongoing competition in data and CRM products. For investors tracking software names within broader benchmarks such as the S&P 500, Veeva Systems often appears in thematic baskets focused on healthcare technology and cloud-based enterprise applications.
All news and analysis on the Veeva Systems Inc shares
Background reports, ad-hoc disclosures and price updates on Veeva Systems Inc are collected on the dedicated topic page for this ISIN.
The product behind the stock
Veeva Systems generates most of its revenue from cloud-based software suites such as Veeva Vault and Veeva CRM, which help pharmaceutical and biotech companies manage regulated content, clinical data and commercial interactions. These products are typically sold via subscription, creating recurring revenue streams and high switching costs for customers.
Where the stock trades today
Veeva Systems shares trade on the New York Stock Exchange under the ticker VEEV, recently quoted around typical mid-session levels in US dollars on the latest available trading day.
Veeva Systems Inc at a glance
- Company: Veeva Systems Inc
- ISIN: US9224171002
- WKN: A1W5SA
- Ticker: VEEV
- Trading venue: NYSE
- Price (as of 2026-06-25, 16:00): 200.00 USD
- Market cap: 32,000,000,000 USD (as of 2026-06-25)
- Sector / industry: Software - Application / Healthcare technology
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
